DEA / Prescribing of Controlled Substances

On May 9, the DEA announced that it will be extending flexibilities regarding telemedicine prescribing of controlled substances until November 11^th, 2023 for new patients and until November 11^th, 2024 for established patients. APA is working on getting more in-depth resources out to its members. You may read the federal announcements below.  

• SAMHSA press release
• Pre-publication rule